Skip to main content
SpringerLink
Log in

Association of IL36RN mutations with clinical features, therapeutic response to acitretin, and frequency of recurrence in patients with generalized pustular psoriasis

  • Genes and Skin
  • Published:
European Journal of Dermatology Aims and scope

Abstract

Background

Previous studies have revealed that IL36RN mutations play a pivotal role in the pathogenesis of generalized pustular psoriasis (GPP), however, the clinical relevance is unclear.

Objectives

To investigate the correlation between IL36RN mutations and clinical features, recurrence frequency, and therapeutic response to acitretin in GPP patients with long-term follow-up.

Materials & Methods

This retrospective cohort study, lasting 2-4 years, included 61 GPP and 48 psoriasis vulgaris (PV) patients.

Results

Sequence analysis of all five exons of the IL36RN gene revealed two genetic variants (c.115+6 T>C and c.227C>T). The cohort was divided into three subgroups according to the c.115+6 T>C mutation (present in 52.5% of the patients): homozygous mutation group (HOMG), heterozygous mutation group (HEMG), and non-mutation group (NMG). Initially, 21/25 HOMG patients were diagnosed with GPP with provocative factors, but 13 developed erythrodermic psoriasis after the pustular phase. Patients in the HEMG (5/7) and NMG (23/29) maintained PV diagnosis before and after the pustular phase. Most patients exhibited a marked response to acitretin, but patients who were prescribed a maintenance dosage (10-30 mg/d) had mild recurrence (0-2 times/year) during follow-up. IL36RN mutations were strongly linked with early onset and hyponychial pustules, but not with therapeutic efficacy of acitretin or recurrence frequency.

Conclusions

Early onset and hyponychial pustules may be specific to IL36RN mutation, however this alone is an insufficient biomarker for acitretin therapy. Other provocative factors play important roles in disease onset, clinical manifestations, and disease outcome. Low-dose maintenance therapy with acitretin might help reduce the recurrence of GPP.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Teoh YL, Tay YK. Generalized pustular psoriasis with a novel mutation of interleukin-36 receptor antagonist, responding to methotrexate. JAAD Case Rep 2015; 1: 51–3.

    Article  PubMed  PubMed Central  Google Scholar 

  2. Adachi A, Komine M, Hirano T, et al. Case of generalized pustular psoriasis exacerbated during pregnancy, successfully treated with infliximab. J Dermatol 2016; 43: 1439–40.

    Article  PubMed  Google Scholar 

  3. Posso-De Los Rios CJ, Pope E, Lara-Corrales I. A systematic review of systemic medications for pustular psoriasis in pediatrics. Pediatr Dermatol 2014; 31: 430–9.

    Article  PubMed  Google Scholar 

  4. Sugiura K. The genetic background of generalized pustular psoriasis: IL36RN mutations and CARD14 gain-of-function variants. J Dermatol Sci 2014; 74: 187–92.

    Article  PubMed  CAS  Google Scholar 

  5. Marrakchi S, Guigue P, Renshaw BR, et al. Interleukin-36-receptor antagonist deficiency and generalized pustular psoriasis. N Engl J Med 2011; 365: 620–8.

    Article  PubMed  CAS  Google Scholar 

  6. Onoufriadis A, Simpson MA, Pink AE, et al. Mutations in IL36RN/IL1F5 are associated with the severe episodic inflammatory skin disease known as generalized pustular psoriasis. Am J Hum Genet 2011; 89: 432–7.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  7. Navarini AA, Simpson MA, Borradori L, Yawalkar N, Schlapbach C. Homozygous missense mutation in IL36RN in generalized pustular dermatosis with intraoral involvement compatible with both AGEP and generalized pustular psoriasis. JAMA Dermatol 2015; 151: 452–3.

    Article  PubMed  Google Scholar 

  8. Sugiura K, Takemoto A, Yamaguchi M, et al. The majority of generalized pustular psoriasis without psoriasis vulgaris is caused by deficiency of interleukin-36 receptor antagonist. J Invest Dermatol 2013; 133: 2514–21.

    Article  PubMed  CAS  Google Scholar 

  9. Körber A, Mössner R, Renner R, et al. Mutations in IL36RN in patients with generalized pustular psoriasis. J Invest Dermatol 2013; 133: 2634–7.

    Article  PubMed  CAS  Google Scholar 

  10. Setta-Kaffetzi N, Navarini AA, Patel VM, et al. Rare pathogenic variants in IL36RN underlie a spectrum of psoriasis-associated pustular phenotypes. J Invest Dermatol 2013; 133: 1366–9.

    Article  PubMed  CAS  Google Scholar 

  11. Li M, Han J, Lu Z, et al. Prevalent and rare mutations in IL-36RN gene in Chinese patients with generalized pustular psoriasis and psoriasis vulgaris. J Invest Dermatol 2013; 133: 2637–9.

    Article  PubMed  CAS  Google Scholar 

  12. Umezawa Y, Ozawa A, Kawasima T, et al. Therapeutic guidelines for the treatment of generalized pustular psoriasis (GPP) based on a proposed classification of disease severity. Arch Dermatol Res 2003; 295: S43–54.

    Article  PubMed  Google Scholar 

  13. Jin H, Li F, He C, et al. Efficacy and safety of Tripterygium wilfordii hook F versus acitretin in moderate to severe psoriasis vulgaris: a randomized clinical trial. Chin Med J 2015; 128: 443–9.

    Article  PubMed  PubMed Central  Google Scholar 

  14. Lv Z, Fan J, Zhang X, et al. Integrative genomic analysis of interleukin-36RN and its prognostic value in cancer. Mol Med Rep 2016; 13: 1404–12.

    Article  PubMed  CAS  Google Scholar 

  15. Tauber M, Bal E, Pei XY, et al. IL36RN mutations affect protein expression and function: a basis for genotype-phenotype correlation in pustular diseases. J Invest Dermatol 2016; 136: 1811–9.

    Article  PubMed  CAS  Google Scholar 

  16. Farooq M, Nakai H, Fujimoto A, et al. Mutation analysis of the IL36RN gene in 14 Japanese patients with generalized pustular psoriasis. Hum Mutat 2013; 34: 176–83.

    Article  PubMed  CAS  Google Scholar 

  17. Sugiura K, Haruna K, Suga Y, Akiyama M. Generalized pustular psoriasis caused by deficiency of interleukin-36 receptor antagonist successfully treated with granulocyte and monocyte adsorption apheresis. J Eur Acad Dermatol Venereol 2014; 28: 1835–6.

    Article  PubMed  CAS  Google Scholar 

  18. Wang TS, Chiu HY, Hong JB, Chan CC, Lin SJ, Tsai TF. Correlation of IL36RN mutation with different clinical features of pustular psoriasis in Chinese patients. Arch Dermatol Res 2016; 308: 55–63.

    Article  PubMed  CAS  Google Scholar 

  19. Aizu T, Matsui A, Takiyoshi N, et al. Elderly-onset generalized pustular psoriasis without a previous history of psoriasis vulgaris. Case Rep Dermatol 2015; 7: 187–93.

    Article  PubMed  PubMed Central  Google Scholar 

  20. Arakawa A, Ruzicka T, Prinz JC. Therapeutic efficacy of interleukin 12/interleukin 23 blockade in generalized pustular psoriasis regardless of IL36RN mutation status. JAMA Dermatol 2016; 152: 825–8.

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Dermatology, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences, Peking Union Medical College, Beijing, 100730, China

    Teng Zhu, Hongzhong Jin, Dan Shu, Feng Li & Chao Wu

Authors
  1. Teng Zhu
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Hongzhong Jin
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Dan Shu
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Feng Li
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Chao Wu
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Hongzhong Jin.

Electronic supplementary material

Table S1.

Primer sequences of IL36RN.

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Zhu, T., Jin, H., Shu, D. et al. Association of IL36RN mutations with clinical features, therapeutic response to acitretin, and frequency of recurrence in patients with generalized pustular psoriasis. Eur J Dermatol 28, 217–224 (2018). https://doi.org/10.1684/ejd.2018.3245

Download citation

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1684/ejd.2018.3245

Key words

Search

Navigation